XML 74 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
3 Months Ended
Aug. 31, 2012
Aug. 31, 2011
Cash flows provided by (used in) operating activities:    
Net loss $ (31.5) $ (39.2) [1]
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 120.6 129.8 [1]
Amortization and write off of deferred financing costs 7.0 2.8 [1]
Stock-based compensation expense 19.1 4.7 [1]
Loss on extinguishment of debt 38.0  
Provision for (recovery) of doubtful accounts receivable 1.3 (2.5) [1]
Loss on impairment of investments   9.2 [1]
Deferred income taxes (68.9) (67.0) [1]
Other (1.3) (0.6) [1]
Changes in operating assets and liabilities, net of acquired assets:    
Accounts receivable 5.8 21.3 [1]
Inventories (21.2) (2.7) [1]
Prepaid expenses (4.2) 2.7 [1]
Accounts payable (8.1) (1.5) [1]
Income taxes (4.2) 22.4 [1]
Accrued interest 51.9 67.8 [1]
Accrued expenses and other (18.8) (24.1) [1]
Net cash provided by operating activities 85.5 123.1 [1]
Cash flows provided by (used in) investing activities:    
Proceeds from sales/maturities of investments   33.7 [1]
Purchases of investments   (0.2) [1]
Net proceeds from sale of property and equipment   0.1 [1]
Capital expenditures (53.1) (39.2) [1]
Acquisitions, net of cash acquired - Trauma Acquisition (280.0)  
Other acquisitions, net of cash acquired (5.9) (3.9) [1]
Cash flows provided by (used in) investing activities (339.0) (9.5) [1]
Debt:    
Payments under European facilities (0.4) (0.5) [1]
Payments under senior secured credit facilities (8.5) (8.9) [1]
Proceeds from Senior notes 1,000.0  
Tender of Senior notes (581.7)  
Payment of fees related to refinancing activities (30.1)  
Equity:    
Repurchase of LVB Acquisition, Inc. shares   (0.3) [1]
Net cash provided by (used in) financing activities 379.3 (9.7) [1]
Effect of exchange rate changes on cash 1.0 (0.5) [1]
Increase in cash and cash equivalents 126.8 103.4 [1]
Cash and cash equivalents, beginning of period 492.4 327.8 [1]
Cash and cash equivalents, end of period 619.2 431.2 [1]
Supplemental disclosures of cash flow information:    
Interest 62.5 55.0 [1]
Income taxes 22.0 20.7 [1]
Biomet, Inc.[Member]
   
Cash flows provided by (used in) operating activities:    
Net loss (31.5) (39.2) [1]
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 120.6 129.8 [1]
Amortization and write off of deferred financing costs 7.0 2.8 [1]
Stock-based compensation expense 19.1 4.7 [1]
Loss on extinguishment of debt 38.0  
Provision for (recovery) of doubtful accounts receivable 1.3 (2.5) [1]
Loss on impairment of investments   9.2 [1]
Deferred income taxes (68.9) (67.0) [1]
Other (1.3) (0.6) [1]
Changes in operating assets and liabilities, net of acquired assets:    
Accounts receivable 5.8 21.3 [1]
Inventories (21.2) (2.7) [1]
Prepaid expenses (4.2) 2.7 [1]
Accounts payable (8.1) (1.5) [1]
Income taxes (4.2) 22.4 [1]
Accrued interest 51.9 67.8 [1]
Accrued expenses and other (18.8) (24.1) [1]
Net cash provided by operating activities 85.5 123.1 [1]
Cash flows provided by (used in) investing activities:    
Proceeds from sales/maturities of investments   33.7 [1]
Purchases of investments   (0.2) [1]
Net proceeds from sale of property and equipment   0.1 [1]
Capital expenditures (53.1) (39.2) [1]
Acquisitions, net of cash acquired - Trauma Acquisition (280.0)  
Other acquisitions, net of cash acquired (5.9) (3.9) [1]
Cash flows provided by (used in) investing activities (339.0) (9.5) [1]
Debt:    
Payments under European facilities (0.4) (0.5) [1]
Payments under senior secured credit facilities (8.5) (8.9) [1]
Proceeds from Senior notes 1,000.0  
Tender of Senior notes (581.7)  
Payment of fees related to refinancing activities (30.1)  
Equity:    
Repurchase of LVB Acquisition, Inc. shares   (0.3) [1]
Net cash provided by (used in) financing activities 379.3 (9.7) [1]
Effect of exchange rate changes on cash 1.0 (0.5) [1]
Increase in cash and cash equivalents 126.8 103.4 [1]
Cash and cash equivalents, beginning of period 492.4 327.8 [1]
Cash and cash equivalents, end of period 619.2 431.2 [1]
Supplemental disclosures of cash flow information:    
Interest 62.5 55.0 [1]
Income taxes $ 22.0 $ 20.7 [1]
[1] Certain amounts have been adjusted to conform to the current presentation.